Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

被引：0
|
作者：
Michael V. Chiorean
Jessica R. Allegretti
Puza P. Sharma
Benjamin Chastek
Leonardo Salese
Elizabeth J. Bell
Jesse Peterson-Brandt
Joseph C. Cappelleri
Xiang Guo
Nabeel Khan
机构：
[1] Swedish Medical Center,Perelman School of Medicine
[2] Brigham and Women’s Hospital,undefined
[3] Pfizer Inc,undefined
[4] Optum Life Sciences,undefined
[5] HEOR,undefined
[6] Pfizer Inc,undefined
[7] Pfizer Inc,undefined
[8] University of Pennsylvania,undefined
来源：
BMC Gastroenterology | / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Tofacitinib is effective as salvage rescue medical therapy in patients with acute severe ulcerative colitis: A real-world case series
    Day, M.
    White, L.
    Kaul, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 179 - 180
  • [42] TREATMENT PERSISTENCE RATES WITH TOFACITINIB IN A REAL-WORLD COHORT OF ANTI-TNF REFRACTORY ULCERATIVE COLITIS PATIENTS
    Conley, Thomas
    Colclough, James
    Liu, Eleanor
    Razanskaite, Violeta
    Jakobek, William
    Limdi, Jimmy
    Flanagan, Paul
    Subramanian, Sreedhar
    GUT, 2021, 70 : A88 - A89
  • [43] Tofacitinib in treatment-experienced patients with ulcerative colitis: A single-center real-world experience in Australia
    Lo, S. W.
    Connell, W.
    Kamm, M. A.
    Lust, M.
    Wright, E. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 122 - 123
  • [44] REAL-WORLD REDUCTION OF ORAL CORTICOSTEROID USE IN PATIENTS TREATED WITH DUPILUMAB AND WITH MODERATE-TO-SEVERE ASTHMA
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A. H.
    Gomez, L. D. P.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J. A.
    VALUE IN HEALTH, 2023, 26 (06) : S38 - S38
  • [45] Real-World Patterns and Economic Burden Associated With Treatment Failure With Advanced Therapies in Patients With Moderate-to-Severe Ulcerative Colitis
    Lee, Scott D.
    Betts, Keith A.
    Du, Ella Xiaoyan
    Nie, Xiaoyu
    Gupte-Singh, Komal
    Ritter, Timothy
    CROHNS & COLITIS 360, 2024, 6 (02)
  • [46] REAL-WORLD RETROSPECTIVE ANALYSIS OF OZANIMOD AND ASSOCIATED CORTICOSTEROID SPARING FOR THE TREATMENT OF ULCERATIVE COLITIS
    Paul, Damemarie
    Nie, Xiaoyu
    Gao, Sophie Y.
    Cato, Matthew
    Shah, Shweta
    Betts, Keith
    Horst, Sara N.
    GASTROENTEROLOGY, 2024, 166 (05) : S1457 - S1458
  • [47] Real-World Retrospective Analysis of Ozanimod and Associated Corticosteroid Sparing for the Treatment of Ulcerative Colitis
    Paul, Damemarie
    Nie, Xiaoyu
    Sundar, Manasvi
    Betts, Keith A.
    Horst, Sara N.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S788 - S788
  • [48] Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience
    D'Amico, Ferdinando
    Parigi, Tommaso Lorenzo
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [49] Efficacy and safety of tofacitinib for the treatment of moderate- severe ulcerative colitis in biologic naive patients
    Liatsos, C.
    Michalopoulos, G.
    Tzouvala, M.
    Giouleme, O.
    Kozompoli, D.
    Mousourakis, K.
    Kyriakos, N.
    Giakoumis, M.
    Striki, A.
    Karoumpalis, I.
    Bellou, G.
    Zacharopoulou, E.
    Katsoula, A.
    Kalogirou, M.
    Viazis, N.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1718 - I1718
  • [50] Real-world clinical and endoscopic outcomes after one year tofacitinib treatment in ulcerative colitis
    Straatmijer, Tessa
    van Gennep, Sara
    Duijvestein, Marjolijn
    Ponsioen, Cyriel I. J.
    Gecse, Krisztina B.
    D'Haens, Geert R.
    Lowenberg, Mark
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (10) : 1288 - 1297
12345